Portfolio Manager Monthly Commentary

June 2016

Amgen, Xencor, and Gilead Sciences were the top positive contributors to performance during the month. Alexion and Biogen underperformed after results of drugs trials. 

Read more »

Register for email alerts

The Biotech Growth Trust PLC conducts its affairs so that its shares can be recommended by independent financial advisers (IFAs) to retail private investors. The shares are excluded from the Financial Conduct Authority's (FCA's) restrictions which apply to non-mainstream investment products because they are shares in a UK-listed investment trust.